International safety notice
Hypovase 0.5 mg tablets – Deletion of all indications of paediatric use of prazosin
Ireland / HPRA · IRL · Mar 8, 2024
Key facts
| Title | Hypovase 0.5 mg tablets – Deletion of all indications of paediatric use of prazosin |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Hypovase 0.5 mg tablets – Deletion of all indications of paediatric use of prazosin |
| Models | 0.5MG, 16-02-2024 |
| Date | Mar 8, 2024 |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1